Teddy Akiki's research is focused on the development of rapid-acting therapeutics for treatment-resistant depression, anxiety, and PTSD (glutamatergic antidepressants such as ketamine, psychedelic compounds, and brain stimulation), precision psychiatry, and understanding the neural underpinnings of trauma- and stress-related disorders (neuroimaging, network neuroscience, computational modeling).


• Psychiatry Residency
Interventional Psychiatry Track
Stanford University
• Psychiatry Residency
Research Track
Cleveland Clinic Foundation
• Postdoctoral Fellowship
Yale University School of Medicine, Department of Psychiatry,
VA National Center for PTSD, Clinical Neurosciences Division


• Outstanding Resident Award Program (ORAP), National Institute of Mental Health, 2021
• Resident-Fellow Research Award, Ohio Psychiatric Physicians Foundation, 2020
• ADAA Travel Award, American College of Neuropsychopharmacology, 2019
• Alies Muskin Career Development Leadership Award, Anxiety and Depression Association of America, 2019
• Young Investigator Award, American Society of Clinical Psychopharmacology, 2018
• New Investigator Award, International Society for CNS Clinical Trials and Methodology, 2018
• Salim El-Hoss Bioethics and Professionalism Award, American University of Beirut, 2015